Analysing age structure, residency and relatedness uncovers social network structure in aggregations of young birds

Animal sociality arises from the cumulative effects of both individual social decisions and environmental factors. While juveniles' social interactions with parents prior to independence shape later life sociality, in most bird and mammal species at least one sex undergoes an early life dispersal before first-year reproduction. The social associations from this period could also have implications for later life yet are rarely characterized. Here, we derived predictions from available examples of juvenile groups in the literature (mobile ‘flocks’, spatially stable ‘gangs’ or adult-associated ‘crèches’) and then used three cohorts of juvenile hihi, Notiomystis cincta, a threatened New Zealand passerine, to demonstrate how multistate modelling and social network analysis approaches can be used to characterize group type based on residency, movement, relatedness and social associations. At sites where hihi congregated, we found that juveniles were resighted at a higher frequency than adults and associated predominantly with unrelated juveniles rather than siblings or parents. Movement between group sites occurred, but associations developed predominantly within the sites. We suggest therefore that juvenile hihi social structure is most similar to a ‘gang’, a group structure in which juveniles congregate without adults at predictable sites. Such gangs have previously only been described formally in ravens, Corvus corax. By combining spatial and social network analyses, our study demonstrates how social group structures can be described and therefore facilitate broader comparisons and discussion about the form and function of juvenile groups across taxa

Onset of the aerobic nitrogen cycle during the Great Oxidation Event

The rise of oxygen on the early Earth (about 2.4 billion years ago)1 caused a reorganization of marine nutrient cycles2, 3, including that of nitrogen, which is important for controlling global primary productivity. However, current geochemical records4 lack the temporal resolution to address the nature and timing of the biogeochemical response to oxygenation directly. Here we couple records of ocean redox chemistry with nitrogen isotope (15N/14N) values from approximately 2.31-billion-year-old shales5 of the Rooihoogte and Timeball Hill formations in South Africa, deposited during the early stages of the first rise in atmospheric oxygen on the Earth (the Great Oxidation Event)6. Our data fill a gap of about 400 million years in the temporal 15N/14N record4 and provide evidence for the emergence of a pervasive aerobic marine nitrogen cycle. The interpretation of our nitrogen isotope data in the context of iron speciation and carbon isotope data suggests biogeochemical cycling across a dynamic redox boundary, with primary productivity fuelled by chemoautotrophic production and a nitrogen cycle dominated by nitrogen loss processes using newly available marine oxidants. This chemostratigraphic trend constrains the onset of widespread nitrate availability associated with ocean oxygenation. The rise of marine nitrate could have allowed for the rapid diversification and proliferation of nitrate-using cyanobacteria and, potentially, eukaryotic phytoplankton

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

Background Real-world data on non-vitamin K oral anticoagulants (NOACs) are essential in determining whether evidence from randomised controlled clinical trials translate into meaningful clinical benefits for patients in everyday practice. RIVER (RIVaroxaban Evaluation in Real life setting) is an ongoing international, prospective registry of patients with newly diagnosed non-valvular atrial fibrillation (NVAF) and at least one investigator-determined risk factor for stroke who received rivaroxaban as an initial treatment for the prevention of thromboembolic stroke. The aim of this paper is to describe the design of the RIVER registry and baseline characteristics of patients with newly diagnosed NVAF who received rivaroxaban as an initial treatment. Methods and results Between January 2014 and June 2017, RIVER investigators recruited 5072 patients at 309 centres in 17 countries. The aim was to enroll consecutive patients at sites where rivaroxaban was already routinely prescribed for stroke prevention. Each patient is being followed up prospectively for a minimum of 2-years. The registry will capture data on the rate and nature of all thromboembolic events (stroke / systemic embolism), bleeding complications, all-cause mortality and other major cardiovascular events as they occur. Data quality is assured through a combination of remote electronic monitoring and onsite monitoring (including source data verification in 10% of cases). Patients were mostly enrolled by cardiologists (n = 3776, 74.6%), by internal medicine specialists 14.2% (n = 718) and by primary care/general practice physicians 8.2% (n = 417). The mean (SD) age of the population was 69.5 (11.0) years, 44.3% were women. Mean (SD) CHADS2 score was 1.9 (1.2) and CHA2DS2-VASc scores was 3.2 (1.6). Almost all patients (98.5%) were prescribed with once daily dose of rivaroxaban, most commonly 20 mg (76.5%) and 15 mg (20.0%) as their initial treatment; 17.9% of patients received concomitant antiplatelet therapy. Most patients enrolled in RIVER met the recommended threshold for AC therapy (86.6% for 2012 ESC Guidelines, and 79.8% of patients according to 2016 ESC Guidelines). Conclusions The RIVER prospective registry will expand our knowledge of how rivaroxaban is prescribed in everyday practice and whether evidence from clinical trials can be translated to the broader cross-section of patients in the real world

Diagnosis and surgical management of a type IV<i>b</i> dermoid sinus in a Cavalier King Charles Spaniel

A 6-year-old, male, neutered Cavalier King Charles Spaniel dog was referred with a 4-year history of an intermittently draining fistula on the midline of the frontal bones of the skull. Magnetic resonance imaging and computed tomography scan of the head demonstrated an extra-axial mass in the midline between the frontal lobes, contacting the meninges and extending rostrally through a defect in the frontal bones. The mass was surgically excised via a frontal craniotomy. Histopathology of the mass demonstrated stratified squamous and keratinising epithelium with adnexal structures, consistent with the diagnosis of a dermoid sinus. Previous reports have documented dermoid sinuses in the nasal region in dogs and cats with intracranial extension. This case report documents a dermoid sinus in the frontal region with intracranial extension in a dog, confirmed by advanced diagnostic imaging, histopathology, and successfully treated surgically